Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03477474 · ClinicalTrials.gov registry record
Registry of Guardant360® Use and Outcomes In People With Advanced Cancer
A clinical trial, sponsored by Guardant Health.
- Terminated
- Registry status
- 311
- Enrollment target
NCT03477474 is a clinical trial that was terminated before completion, run by Guardant Health. The registered enrollment target is 311 participants.
The verdict
NCT03477474 was terminated before completion, sponsored by Guardant Health.
- TERMINATED
- Registry status
- 311 participants
- Enrollment target
Study Summary
The purpose of this registry is to collect data that describes the characteristics of people with advanced cancer for whom the Guardant360 assay is ordered and to observe their clinical outcomes after receiving their results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 311 participants |
| Start Date | 2018-04-06 |
| Est. Completion | 2019-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03477474
The ClinicalTrials.gov registry entry for NCT03477474 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 311 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Guardant Health, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03477474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03477474 about?
NCT03477474 is a clinical study titled "Registry of Guardant360® Use and Outcomes In People With Advanced Cancer". The purpose of this registry is to collect data that describes the characteristics of people with advanced cancer for whom the Guardant360 assay is ordered and to observe their clinical outcomes after receiving their results.
What is the current status of trial NCT03477474?
This trial is currently terminated. The enrollment target is 311 participants. The study started on 2018-04-06. Estimated completion is 2019-09-01.
Who is sponsoring clinical trial NCT03477474?
This trial is sponsored by Guardant Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.